abstract |
The present invention relates to inhibitors of IGFBP3 and their use for the treatment and / or prevention of intestinal diseases, in particular diabetic enteropathy or inflammatory bowel disease. The invention also relates to IGFBP3 and its use for the diagnosis and prediction of intestinal diseases, in particular diabetic or inflammatory bowel diseases. |